#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vascular calcification Marginal zone lymphoma refractory Neutropenia Soft tissue sarcoma Chronic kidney disease Loeys-Dietz syndrome Malignant neoplasm of choroid Fibrosarcoma Kaposi's sarcoma Leukodystrophy Measles Hypochromic anaemia Hereditary optic atrophy Adrenocortical carcinoma IgA nephropathy More trials…

    Learn about Rare Diseases

    KBG syndrome – Treatment Skin angiosarcoma – Diagnostics Marginal zone lymphoma – Treatment Methylmalonic acidaemia – Basic Information Pulmonary sarcoidosis – Life with Disease X-linked lymphoproliferative syndrome – Trials in Disease Haemolytic uraemic syndrome – Diagnostics Mucopolysaccharidosis I – Basic Information Angelman’s syndrome – Basic Information Chronic granulomatous disease – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vedolizumab Tislelizumab Syn2 Serpina1(Human)-Aav8-1 Triglycerides, Medium Chain Crisantaspase Abc-35B-116 Spesolimab Fluvastatin Sodium Dexketoprofen Autologous Pancreatic Islets Abc-15A-116 Triamcinolone Hexacetonide Sot102 Auto4 H2-Receptor Antagonists Ephedrine Hydrochloride HUMAN FIBROBLASTS Celecoxib Temsirolimus More therapies…

    Learn about Your Condition

    Generalised anxiety disorder Albright's disease Malignant oligodendroglioma Myocarditis Salivary gland cancer EGFR gene mutation Pulmonary alveolar haemorrhage Breast cancer stage IV Noonan syndrome Noninfective chorioretinitis Biotinidase deficiency Adenovirus infection Malignant melanoma stage II Complicated appendicitis Testicular germ cell cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Open angle glaucoma

  • Study on the Effectiveness of Citicoline Eye Drops for Visual Field Preservation in Patients with Open Angle Glaucoma

    Recruiting

    3 1
    Investigated Diseases:
    • Exfoliation glaucoma
    • Pigmentary glaucoma
    • Open angle glaucoma
    Investigated Drugs:
    • Citicoline Sodium
    Belgium France Greece Hungary Italy Poland +1

  • Study on Goblet Cell Density in Patients with Ocular Hypertension or Primary Open Angle Glaucoma Using Benzalkonium Chloride and Latanoprost Eye Drops

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Ocular hypertension
    • Open angle glaucoma
    Investigated Drugs:
    • Latanoprost
    Denmark

  • Study on the Effects of Bimatoprost SR and Timolol in Patients with Open-angle Glaucoma or Ocular Hypertension

    Not recruiting

    3 1
    Investigated Drugs:
    • Timolol Maleate
    • Bimatoprost
    Germany

  • Study Comparing Bimatoprost Eye Drops with Lumigan for Patients with Chronic Open-Angle Glaucoma or Ocular Hypertension

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Ocular hypertension
    • Open angle glaucoma
    Investigated Drugs:
    • Bimatoprost
    Italy

  • Study Comparing Brimonidine and Timolol Eye Drops for Patients with Open-Angle Glaucoma or Ocular Hypertension

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Ocular hypertension
    • Open angle glaucoma
    Investigated Drugs:
    • Timolol Maleate
    • Brimonidine Tartrate
    Greece

  • Study on Glaucoma Treatment: Comparing Brimonidine, Pilocarpine Nitrate, and Brinzolamide in Patients with Newly Diagnosed Open-Angle Glaucoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Exfoliation glaucoma
    • Open angle glaucoma
    Investigated Drugs:
    • Betaxolol
    • Brimonidine
    • Brinzolamide
    Sweden
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!